CliffBio

Eton Pharmaceuticals

Patent cliffs & loss of exclusivity

505(b)(2) drugs

Company

CAGE Code85RB4
Legal NameEton Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/eton-pharmaceuticals
Full Address21925 W. Field Pkwy #235 Deer Park, IL 60010, USA
LinkedIn URLhttps://www.linkedin.com/company/etonpharma/
Pitchbook URLhttps://pitchbook.com/profiles/company/182408-32
Stock SymbolETON

7 upcoming patent cliffs

DrugIngredientTypeCliff
  1. IncrelexmecaserminBiologicAug 2017
  2. HEMANGEOLPROPRANOLOL HYDROCHLORIDESmall mol.Oct 2028
  3. ALKINDI SPRINKLEHYDROCORTISONESmall mol.May 2034
  4. ALKINDI SPRINKLEHYDROCORTISONESmall mol.May 2034
  5. ALKINDI SPRINKLEHYDROCORTISONESmall mol.May 2034
  6. ALKINDI SPRINKLEHYDROCORTISONESmall mol.May 2034
  7. KHINDIVIHYDROCORTISONESmall mol.Feb 2043
  8. DESMODADESMOPRESSIN ACETATESmall mol.Apr 2044
  9. GALZINZINC ACETATESmall mol.—
  10. GALZINZINC ACETATESmall mol.—
  11. NITISINONENITISINONESmall mol.—
  12. NITISINONENITISINONESmall mol.—
  13. NITISINONENITISINONESmall mol.—
  14. NITISINONENITISINONESmall mol.—
  15. BETAINEBETAINESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Eton Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio